FDA plaque subcommittee meeting
This article was originally published in The Tan Sheet
Executive Summary
Dental Products Panel's Plaque Subcommittee to meet Dec. 5-7, FDA announces in Nov. 16 Federal Register. On Dec. 6, the subcommittee will meet jointly with the agency's Dental Products Panel. Discussion on all three days will focus on: the possible relationship of alcohol-containing mouthwashes to oral and pharyngeal cancers; the drug/cosmetic status of antiplaque products and claims; and general guidelines for determining the safety and effectiveness of antiplaque products. The joint meeting will also address definitions and general information related to antiplaque products and claims. A draft version of the advanced notice of proposed rulemaking on antiplaque products developed by the subcommittee will be presented at the joint session. The meeting begins at 9 a.m. each day at the Renaissance Hotel at Techworld in Washington, D.C
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning